Interestingly, AET reduces serum TNF-α levels [22] and plasma inflammatory markers (e.g., soluble cell adhesion molecule-1, soluble vascular cell molecule-1, and macrophage chemoattractant) [154] in trained HF patients. The gene discussed is TNF; the disease is hydrops fetalis.